BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Wednesday, April 17, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Dec. 17, 2014
View Archived Issues
Janssen Therapeutics collaborates with USAID on multidrug-resistant TB initiative
Read More
Innate Immunotherapeutics expands compassionate use access to MS drug MIS-416
Read More
Pfizer initiates phase I trial of PF-06700841 in healthy adults and adults with plaque psoriasis
Read More
Inhibition of hydrogen sulfide gas production reduces chemotherapy-induced neuropathic pain
Read More
Arrest or reversion of liver disease by dual FXR/TGR5 agonist INT-767 in preclinical models
Read More
Alcon Research begins phase III trial of RTH-258
Read More
Novel anti-PD-L1/IL-15 fusion protein enhances immunological activity against tumor cells
Read More
OPKO Health and Pfizer enter into global agreement for hGH-CTP
Read More
Activity of fully human bispecific antibody against B-cell lymphoma described
Read More
FDA grants orphan drug status to ataluren for mucopolysaccharidosis type I
Read More
Galapagos regains rights to GLPG-1205
Read More
Allergan patent details novel EP2 receptor agonists for ocular diseases
Read More
Edison Pharmaceuticals develops compounds for oxidative stress disorders
Read More
Bristol-Myers Squibb researchers prepare MGAT2 inhibitors
Read More
XuanZhu Pharma patent divulges novel ALK inhibitors for cancer
Read More
Hinova Pharmaceuticals patents new AR antagonists
Read More
Cushing's syndrome treatment Ketoconazole HRA receives European marketing authorization
Read More
Ablynx initiates phase IIa trial of ALX-0171 in infants with RSV infection
Read More
FDA approves Ipsen's lanreotide depot for pancreatic and gastrointestinal neuroendocrine tumors
Read More
CSL Behring submits BLA to FDA for rIX-FP
Read More
Irisin identified as a biomarker for heart failure prognosis
Read More
Topline data from Auspex's First-HD study of SD-809
Read More
ADMA Biologics receives milestone payment for achievement of RI-002 clinical endpoints
Read More
Kymab to lead Wellcome Trust-funded Ebola virus consortium
Read More
FDA gives clearance to diaDexus Lp-PLA2 test for risk of coronary heart disease
Read More